Advanced Search Results For "KAM, KEN"
Your filters
68Ga-PSMA PET/CT versus CT and bone scan for investigation of PSA failure post radical prostatectomy
Publication Type: Academic Journal
Source(s): Asian Journal of Urology, Vol 8, Iss 2, Pp 170-175 (2021)
Abstract: Objective: To evaluate the use of Gallium-68 prostate-specific membrane antigen positron emission tomography/computed tomography (68Ga-PSMA PET/CT), compared with conventional CT abdomen/pelvis (CTAP) and whole body single photon emission CT bone scan ...
Microstructural Effect on the Enhancement of Field Electron Emission Properties of Nanocrystalline Diamond Films by Li-Ion Implantation and Annealing Processes
Publication Type: Academic Journal
Source(s): ACS Omega, Vol 3, Iss 8, Pp 9956-9965 (2018)
PEMT, Δ6 desaturase, and palmitoyldocosahexaenoyl phosphatidylcholine are increased in rats during pregnancy[S]
Publication Type: Academic Journal
Source(s): Journal of Lipid Research, Vol 59, Iss 1, Pp 123-136 (2018)
Abstract: DHA is important for fetal neurodevelopment. During pregnancy, maternal plasma DHA increases, but the mechanism is not fully understood. Using rats fed a fixed-formula diet (DHA as 0.07% total energy), plasma and liver were collected for fatty acid pro...
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Publication Type: Periodical
Source(s): The Lancet; February 2022, Vol. 399 Issue: 10325 p665-676, 12p
Abstract: Casirivimab and imdevimab are non-competing monoclonal antibodies that bind to two different sites on the receptor binding domain of the SARS-CoV-2 spike glycoprotein, blocking viral entry into host cells. We aimed to evaluate the efficacy and safety o...
Variants at the APOE/C1/C2/C4 Locus Modulate Cholesterol Efflux Capacity Independently of High‐Density Lipoprotein Cholesterol
Publication Type: Academic Journal
Source(s): Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 16 (2018)
Abstract: Background Macrophage cholesterol efflux to high‐density lipoproteins (HDLs) is the first step of reverse cholesterol transport. The cholesterol efflux capacity (CEC) of HDL particles is a protective risk factor for coronary artery disease independent ...
060 PREVALANCE AND OUTCOME OF ACUTE KIDNEY INJURY IN DENGUE PATIENTS IN SUBURBAN AREA OF PAHANG
Publication Type: Academic Journal
Source(s): Kidney International Reports, Vol 2, Iss 4, p S5 (2017)
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Publication Type: Periodical
Source(s): The Lancet; January 2022, Vol. 399 Issue: 10320 p143-151, 9p
Abstract: Aspirin has been proposed as a treatment for COVID-19 on the basis of its anti-thrombotic properties. We aimed to evaluate the efficacy and safety of aspirin in patients admitted to hospital with COVID-19.
Presence of proNGF-Sortilin Signaling Complex in Nigral Dopamine Neurons and Its Variation in Relation to Aging, Lactacystin and 6-OHDA Insults
Publication Type: Academic Journal
Source(s): International Journal of Molecular Sciences, Vol 14, Iss 7, Pp 14085-14104 (2013)
Abstract: Growing evidence has shown that proNGF-p75NTR-sortilin signaling might be a crucial factor in neurodegeneration, but it remains unclear if it may function in nigral neurons under aging and disease. The purpose of this study is to examine and quantify p...
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
Publication Type: Periodical
Source(s): The Lancet; May-June 2021, Vol. 397 Issue: 10289 p2049-2059, 11p
Abstract: Many patients with COVID-19 have been treated with plasma containing anti-SARS-CoV-2 antibodies. We aimed to evaluate the safety and efficacy of convalescent plasma therapy in patients admitted to hospital with COVID-19.
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Publication Type: Periodical
Source(s): The Lancet; May 2021, Vol. 397 Issue: 10285 p1637-1645, 9p
Abstract: In this study, we aimed to evaluate the effects of tocilizumab in adult patients admitted to hospital with COVID-19 with both hypoxia and systemic inflammation.